Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: Updated analysis of 51 patients

Mathieu S. Bolhuis*, Richard van Altena, Jan-Willem C. Alffenaar

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

7 Citations (Scopus)
238 Downloads (Pure)
Original languageEnglish
Pages (from-to)2055-2056
Number of pages2
JournalJournal of Antimicrobial Chemotherapy
Volume67
Issue number8
DOIs
Publication statusPublished - 27-Apr-2012

Keywords

  • TB
  • efficacy
  • tolerability
  • adverse events
  • therapeutic drug monitoring

Cite this